特非那定的心脏毒性与国内外应用概况

摘要/Abstract

摘要： 目的综述特非那定的心脏毒性与国内外应用概况，为临床安全、合理用药提供参考。方法查阅国内外相关文献对特非那定在国内外上市及监管情况进行回顾并对其心脏毒性研究进展进行分析，对该药在我国的使用状况及出现的不良反应进行总结。结果特非那定具有较为明确的心脏毒性，在过量或血药浓度增高时更为明显，该药于20世纪九十年代末在欧美等国家撤市或限制使用，目前在我国以处方药管理，也有相关的不良反应报道。结论临床应警惕该药的不良反应，规范用药剂量及合并药物，提高临床用药的有效性和安全性。

关键词: 特非那定, 心脏毒性, 不良反应

Abstract: Objective The cardiotoxicity of Terfenadine and its application profile in the world were reviewed in this article. The references of clinical rational and safe use of the drug were provided. MethodsWe accessed relevant literature of Terfenadine withdrawal from the market in some countries and analysed the research on the cardiac toxicity of the drug, and summarized the application and adverse reactions of this drug in China. ResultsAnalysis showed that Terfenadine has cardiac toxicity, when overdosed or increased blood concentration the adverse reaction was easy to happen. Although the drug was withdrawn or was restricted in use in the late 1990s, Terfenadine is still used in China as prescription drug, and the adverse reactions were reported in recent years. ConclusionThe clinical adverse drug reactions should be alert. The dosage and combination drugs should be specified, in order to improve the safety and effectiveness for clinical medication.

Key words: Terfenadine, cardiotoxicity, adverse drug reaction

毛璐，王楠. 特非那定的心脏毒性与国内外应用概况[J]. 中国药物警戒, 2012, 9(6): 347-349.

MAO Lu, WANG Nan. The Cardiotoxicity of Terfenadine and Application Profile[J]. Chinese Journal of Pharmacovigilance, 2012, 9(6): 347-349.

参考文献

[1] 赵志刚,王爱国. 当代药品商品名与别名辞典[M].2006. 北京：化学工业出版社. 451.
[2] 刘茂顺,范建荣,訾梅. 特非那丁的药物流行病学概况及应用价值评价[J]. 药物流行病学杂志, 1999,8(3):129-132.
[3] Woosley RL, Chen Y, Freiman Jea. Mechanism of the cardiotoxic actions of terfenadine[J]. JAMA, 1993,256(12):1532-1536.
[4] Terfenadine to be withdrawn in the US[J]. Reactions Weekly, 1998,683(10 Jan):2.
[5] Terfenadine: prescription only status recommended in UK[J]. Reactions Weekly, 1997,650(May 10):2
[6] Terfenadine and astemizole will be reclassified to prescription-only in Canada[J]. Reaction weekly, 1997,682(20):2.
[7] 刘萍. 大剂量特非那定已被停用[J].药学进展, 1999,23(3):188.
[8] Davies AJ, Harindra V, McEwan A et al. Cardiotoxic effect with convulsions in terfenadine overdose[J]. BMJ, 1989,298(6669):325.
[9] Glassman AH, Thomas Bigger J. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death[J]. American journal of psychiatry, 2001,158(11):1774-1782.
[10] Rajput SK, Singh JN, Sharma SS. Evaluation of terfenadine and ketoconazole-induced QT prolongation in conscious telemetered guinea pigs[J]. Pharmacological Reports, 2010,62(4):683-688.
[11] 吕吉元等. 特非那丁对心律失常防治作用的研究[J].中华心律失常学杂志, 2009,13(4):279-282.
[12] Aslanian R, Piwinski JJ, Zhu X. Structural determinants for histamine H1 affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs[J]. Bioorganic & Medicinal Chemistry Letters, 2009,19(17):5043-5047.
[13] 国家食品药品监督管理局.什么是药物相互作用[EB/OL].[2012-01-05] http://former08.sfda.gov.cn/WS01/CL0112/23734.html.
[14] 国家食品药品监督管理局.什么是药物相互作用[EB/OL]. [2012-01-05] http://www.sfda.gov.cn/WS01/CL0445/28914.html.
[15] 国家食品药品监督管理局信息中心.数据查询[EB/OL]. http://app1.sfda.gov.cn/datasearch/face3/base.jsp.
[16] 孙宇,刁树玲,王文英. 特非那定致尖端扭转性室性心动过速一例[J]. 中华心律失常学杂志, 2001,5(1):43.
[17] 张建军,王洋. 特非那定致严重心脏毒性1例[J].中国医学创新, 2010,7(21):192.
[18] 万雨明,李明. 特非那定致窦性心动过缓伴心律不齐1 例[J]. 中国临床药学杂志, 2000,9(4):248.
[19] 卫应. 警惕特非那定的心脏毒性[J]. 药物不良反应杂志, 2001,3(1):36.
[20] 蒋亚生,时晓鸿. 特非那定的临床不良反应分析[J]. 中国药业, 2000,9(11):56.